AVR anteris technologies global corp.

Ann: Exceptional Results in Second Valve-in-Valve Case, page-22

  1. 348 Posts.
    lightbulb Created with Sketch. 34
    Firstly I don’t think HDE is the ultimate pathway Anteris is looking for as there is an annual quota how many devices can be sold for profit each year if I read it correctly.

    Secondly, if VIV is not something Anteris is looking for PMA ultimately then why are they making it available for the Special Access Program in Canada?

    I suspect VIV might be incorporated in the EFS or pivotal study somehow?

    Not advice, DYOR
    Last edited by codeai: 14/08/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$6.00
Change
-0.030(0.50%)
Mkt cap ! $92.99M
Open High Low Value Volume
$6.01 $6.03 $5.84 $85.53K 14.32K

Buyers (Bids)

No. Vol. Price($)
1 333 $6.00
 

Sellers (Offers)

Price($) Vol. No.
$6.25 1000 1
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.